Cubist Systematic Strategies’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-267
Closed -$30.3K 3755
2023
Q4
$30.3K Buy
+267
New +$23.2K ﹤0.01% 3317
2022
Q4
Sell
-6,635
Closed -$412K 4268
2022
Q3
$412K Sell
6,635
-3,462
-34% -$249K ﹤0.01% 3313
2022
Q2
$675K Sell
10,097
-27,953
-73% -$2.1M ﹤0.01% 2808
2022
Q1
$2.73M Buy
38,050
+15,644
+70% +$1.28M 0.02% 1226
2021
Q4
$2.15M Buy
22,406
+4,840
+28% +$328K 0.02% 1301
2021
Q3
$859K Sell
17,566
-24,875
-59% -$1.25M 0.01% 1641
2021
Q2
$2.13M Buy
42,441
+22,315
+111% +$1.1M 0.02% 1040
2021
Q1
$789K Buy
20,126
+8,061
+67% +$313K 0.01% 1680
2020
Q4
$353K Buy
+12,065
New +$308K ﹤0.01% 1956
2018
Q4
Sell
-8,439
Closed -$266K 2066
2018
Q3
$266K Buy
+8,439
New +$304K 0.01% 1248

Other funds holding BXC

Cubist Systematic Strategies's BXC Position: Q1 2024 in Review

Cubist Systematic Strategies sold out of BlueLinx (BXC) in Q1 2024, closing a stake of 267 shares — an estimated $30.3K sold.

Cubist Systematic Strategies first reported a position in BXC in Q3 2018 and held it in 10 quarters. The position peaked at $2.73M in Q1 2022. 181 funds tracked by Wall St. Rank hold BXC as of Q1 2024.

  • Cubist Systematic Strategies reported no remaining BlueLinx position as of Q1 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 267 BlueLinx shares in Q1 2024, an estimated $30.3K.
  • Cubist Systematic Strategies first reported a position in BlueLinx in Q3 2018 and held it in 10 quarters.
  • Cubist Systematic Strategies's BlueLinx position peaked at $2.73M in Q1 2022.
  • 181 funds tracked by Wall St. Rank held BlueLinx as of Q1 2024.

Based on Cubist Systematic Strategies's 13F filing for Q1 2024, filed 15 May 2024.